|
AQST Aquestive Therapeutics Inc 1398733 |
| Balance Sheet |
|
Current Assets
|
$118,494,000.00 |
|
Assets
|
$132,104,000.00 |
|
Current Liabilities
|
$16,478,000.00 |
|
Liabilities
|
$188,690,000.00 |
|
Equity
|
$-56,586,000.00 |
|
Shares Out
|
125511648.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-24,247,000.00 |
|
Investing Cash Flow
|
$-264,000.00 |
| Market Analysis |
Market Cap
|
$564,802,416.00 |
|
Price
|
$4.50 |
|
PB
|
1.52 |
|
EPS
|
-0.18 |
|
PS
|
10.22 |
|
FCF
|
$-24,511,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:39 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:29 |
|
| Apr |
May |
Jun |
| 2026-03-04 |
-0.26 |
|
|
2026-05-13 |
-0.07 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-11 |
-0.14 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-05 |
-0.14 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view AQST documents filed with the SEC.
AQST Filings
Clear
